Meta-analysis supports low FODMAP for IBS

An Australian meta-analysis has found that low-FODMAP diets reduce symptom severity scores, abdominal pain, bloating and overall symptoms in irritable bowel syndrome.

The study includes six randomised controlled trials and 16 non-randomised interventions that measure either IBS symptom severity scores (SSS) or IBS quality of life (QOL) scores before and after the intervention.

Low FODMAP diets, which were developed at Monash University, are low in fermentable oligo, di- and mono-saccharides and polyols.